Chuangzhou Rao

581 citations
23 papers · 149 indexed · h-index 7
Topics
Lung Cancer Treatments and Mutations (13 papers)Lung Cancer Research Studies (7 papers)Lung Cancer Diagnosis and Treatment (6 papers)
Partner nations
ChinaUnited States

In The Last Decade

Chuangzhou Rao

20 papers receiving 147 citations

Peers

Chuangzhou Rao
Comparison fields: 5 of 28
  • Cancer Research 82
  • Molecular Biology 78
  • Pulmonary and Respiratory Medicine 61
  • Oncology 55
  • Surgery 12
Replace Miguel García-Pardo with:
Miguel García-Pardo Canada
Rowena Sharpe United Kingdom
Corrin A. Wohlhieter United States
Natalja Eigėlienė Finland
Antoine Vasseur France
Genovefa Polychronidou Greece
Zhihong Zhang China
Jamie Xie United States
Zi-Yang Peng China
Tiffani McKenzie United States
Chuangzhou Rao relative to Miguel García-Pardo Canada Miguel García-Pardo's profile →
Citations per field
00.5×11.5×
Miguel García-Pardo · 1×
Citations per year

Countries citing papers authored by Chuangzhou Rao

Since Specialization
Citations

This map shows the geographic impact of Chuangzhou Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuangzhou Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuangzhou Rao more than expected).

Fields of papers citing papers by Chuangzhou Rao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuangzhou Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuangzhou Rao. The network helps show where Chuangzhou Rao may publish in the future.

Co-authorship network of co-authors of Chuangzhou Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Chuangzhou Rao. A scholar is included among the top collaborators of Chuangzhou Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuangzhou Rao. Chuangzhou Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 1
5 0
6 0
7 2
8 8
9 6
10 31
11 11
12 1
13 23
14 2
15 30
16 1
17 4
18 13
19 10
20 1

About Chuangzhou Rao

Chuangzhou Rao is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 149 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (7 papers) and Lung Cancer Diagnosis and Treatment (6 papers). The work is most often cited by research in Cancer Research (82 citations), Oncology (55 citations) and Pulmonary and Respiratory Medicine (61 citations). Chuangzhou Rao has collaborated with scholars based in China and United States. Frequent co-authors include Minglei Yang, Guofang Zhao, Gang Hua, Chen Zhang, Haibo Shen, Caijun Dong, Wen Lin, Xiaohua Hu, Xinghao Ai and Jiuwei Cui. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026